A. Karreman

Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.

F. Verheugt, G. Veen, M. Brouwer, 2008, American heart journal.

Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging.

J Valk, A. van Rossum, C. Visser, 1995, American heart journal.

Comparison of 17-iodine-131 heptadecanoic acid kinetics from externally measured time-activity curves and from serial myocardial biopsies in an open-chest canine model.

A. van Lingen, J. P. Roos, M. J. van Eenige, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Analysis of Myocardial Time-Activity Curves of 123l-Heptadecanoic Acid II. The Acquisition Time

J. P. Roos, M. J. van Eenige, F. Visser, 1987, Nuklearmedizin.

Analysis of Myocardial Time-Activity Curves of 123I-Heptadecanoic Acid I. Curve Fitting

J. P. Roos, M. J. van Eenige, F. Visser, 1987, Nuklearmedizin.

High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.

F. Verheugt, G. Veen, M. Brouwer, 2004, American heart journal.

Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study.

C. Visser, O. Kamp, C. Visser, 1997, Journal of the American College of Cardiology.